News about Manufacturing

Cipla USA Recalls Cancer Drug Batches Over Manufacturing Issue

The recall involves Nilotinib capsules in two strengths—150 mg and 200 mg—distributed in the US market. The affected batches include a total of 435 cartons, comprising 271 cartons from one lot and 164 from another.

Manufacturing | 09/03/2026 | By Darshana |  188

Servier Strikes USD 2.5 Billion Deal to Buy Day One Biopharmaceuticals

French drugmaker Servier has agreed to acquire US-based Day One Biopharmaceuticals in an all-cash deal valued at approximately USD 2.5 billion, as the company seeks to strengthen its presence in rare oncology and brain tumour therapies.

Manufacturing | 07/03/2026 | By Darshana |  131

Ultrasound AI Secures FDA De Novo Clearance for Delivery Date AI Technology

FDA grants De Novo clearance to cloud-based Delivery Date AI, enabling real-time predicted delivery dates from standard ultrasound images to support clinical decisions in pregnancies with uncertain dating.

Manufacturing | 03/03/2026 | By News Bureau |  563

Quotient Sciences Expands Commercial Supply Partnership with Ipsen for Ultra-Rare FOP Therapy

Quotient Sciences has announced an extension of its commercial supply partnership with Ipsen to manufacture a treatment for fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder affecting fewer than 1,000 people worldwide.

Manufacturing | 01/03/2026 | By Darshana |  114

Lupin Limited Receives USFDA EIR for Goa Manufacturing Facility

Lupin Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration for its manufacturing facility in Goa. The report follows a recent inspection of the site and marks the formal closure of the regulatory review process.

Manufacturing | 01/03/2026 | By Darshana |  149

Indoco Remedies Secures US FDA Approval for Generic Brivaracetam Oral Solution

Indoco Remedies receives US FDA approval to market generic brivaracetam oral solution for partial-onset seizures in the US market.

Manufacturing | 24/02/2026 | By News Bureau |  143

UK Medicines Manufacturing Faces Acute Skills Gap; VR Training Boosts Competency by 40 percent

Advanced medicines manufacturing in the UK is grappling with a significant skills shortage, with too few young professionals entering the sector, according to Ivan Wall, Professor of Regenerative Medicine at University of Birmingham and co-director of RESILIENCE: UK Medicines Manufacturing Skills Centre of Excellence.

Manufacturing | 24/02/2026 | By Darshana |  118

Johnson & Johnson to Invest Over $1 Billion in Pennsylvania Cell Therapy Manufacturing Facility

Johnson & Johnson (JNJ) has announced an investment of more than $1 billion to build a next-generation cell therapy manufacturing facility in Montgomery County, Pennsylvania.

Manufacturing | 20/02/2026 | By Darshana |  137

Lilly Positions India as Global Manufacturing Hub Amid Mounjaro Demand

Eli Lilly and Company is moving to position India as a strategic global manufacturing and export hub, supported by strong demand for its blockbuster diabetes and obesity therapy Mounjaro. A senior executive said the company is advancing plans to integrate India more deeply into its worldwide supply chain through contract manufacturing partnerships.

Manufacturing | 18/02/2026 | By Darshana |  273

Dewpoint Therapeutics Inc advances MYC small molecule toward oncology development manufacturing

Dewpoint Therapeutics Inc., a biotechnology company developing condensate-modulating medicines, has selected a development candidate for its MYC oncology programme, marking a key step toward advancing a first-in-class small molecule designed to regulate MYC-driven cancer biology.

Manufacturing | 15/02/2026 | By Darshana |  144